TLRY stock icon

Tilray
TLRY

$1.90
2.59%

Market Cap: 1.57B

 

About: Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Employees: 1,600

0
Funds holding %
of 6,702 funds
Analysts bullish %
0
News positive %
of 39 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

31% more capital invested

Capital invested by funds: $161M [Q4 2023] → $211M (+$50.3M) [Q1 2024]

2.11% more ownership

Funds ownership: 9.41% [Q4 2023] → 11.52% (+2.11%) [Q1 2024]

8% less first-time investments, than exits

New positions opened: 61 | Existing positions closed: 66

8% less call options, than puts

Call options by funds: $31.2M | Put options by funds: $33.9M

8% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 84

1% less funds holding

Funds holding: 346 [Q4 2023] → 341 (-5) [Q1 2024]

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$2
5%
upside
Avg. target
$2
5%
upside
High target
$2
5%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
CIBC
John Zamparo
5%upside
$2
Neutral
Maintained
10 Apr 2024

Financial journalist opinion

Based on 39 articles about TLRY published over the past 30 days